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The United States Pharmacopeia (USP) General Chapters Dissolution 〈711〉 and Disintegration and Dis-
solution of Dietary Supplements 〈2040〉 allows the use of enzymes in dissolution media when gelatin
capsules do not conform to dissolution speciﬁcations due to cross linking. Possible interactions between
enzymes and surfactants when used together in dissolution media could result in loss of the enzymatic
activity. Pepsin is an enzyme commonly used in dissolution media, and in this work, the activity of
pepsin was determined in the presence of different surfactants as usually found in case of dissolution
tests of certain gelatin capsule formulations.
Pepsin enzymatic activity was determined according to the Ninth Edition of the Food Chemicals Codex
(FCC) 9 method, in dissolution conditions: simulated gastric ﬂuid, 37 °C and 50 rpm. Sodium dodecyl
sulfate (SDS), cetyltrimethyl ammonium bromide (CTAB), polysorbate 80 (Tween 80) and octoxynol 9
(Triton X100) in concentrations above and below their critical micellar concentrations were selected.
Results showed a signiﬁcant reduction in the activity of pepsin at all the concentrations of SDS assayed.
On the contrary, CTAB, Tween 80, and Triton X100 did not alter the enzymatic activity at of pepsin any of
the concentration assayed.
This data demonstrates a rational selection of the surfactant to be used when pepsin is required in
dissolution test.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The United States Pharmacopeia (USP) General Chapters Dis-
solution 〈711〉 [29] and Disintegration and Dissolution of Dietary
Supplements 〈2040〉 allow the addition of enzymes to the dis-
solution medium when gelatin capsules and gelatin-coated tablets
do not conform to the dissolution speciﬁcation due to cross-
linking of gelatin. Cross-linking entails the formation of strong
chemical linkages between gelatin chains due to interactions with
the ﬁlling material or between the gelatin and the environment
during storage [32]. The covalent bonding produced with this type
of cross-linking is, for all practical purposes, irreversible, and will
eventually render the gelatin insoluble.
Cross-linking typically results in the formation of a pellicle on
the internal or external surface of the gelatin capsule shell that
prevents the capsule ﬁll from being released. In vitro dissolutionB.V. This is an open access article u
ratory Department: Research
ille, MD 20852-1790, USA.testing of cross-linked capsules can result in slower or incomplete
release of the active ingredient or no release at all [14,7]. The
degree of cross-linking is not usually uniform within one capsule
or among different capsules. As consequence, dissolution results
will have higher variability when gelatin capsules are cross-linked
[10,16,5,7].
When the gelatin is no longer soluble in water, dissolution of
the shell must involve the breaking of other bonds, e.g., by
enzyme-mediated breaking of peptide bonds in protein chains.
The pH of the dissolution medium determines the appropriate
enzyme to be used according to 〈711〉 and 〈2040〉 [31].
Pepsin is the enzyme commonly used in acidic dissolution
media (pH 1 to pH 4) to break peptide bonds in gelatin capsules
that are affected by cross linking. Pepsin is a monomeric, two
domain, mainly L-protein, with a high percentage of acid residues
(43 out of 327) leading to its very low isoelectric point (IEP)E1. It
catalyzes the hydrolysis of peptide bonds between two hydro-
phobic amino acids [1]. The catalytic site of pepsin is formed by
two aspartate residues, Asp32 and Asp215 (pKa values about
1.4 and 4.5, respectively), one of which has to be protonated, andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
M.L Guzman et al. / Results in Pharma Sciences 6 (2016) 15–1916the other deprotonated, for the protein to be active. This occurs in
the pH range between 1 and 5 [6].
The proteolytic activity of pepsin is affected by the conditions
of the dissolution medium. In acidic dissolution media like simu-
lated gastric ﬂuid (SGF, pH 1.2, 37 °C), pepsin shows its maximum
activity. In fact, porcine pepsin has optimal activity at pH
approximately 2.2. At pH 4.5 it decays to about 35% [3]. Within a
pH range of 2–4, the enzymatic activity of pepsin is not affected by
temperature changes between 4 °C and 37 °C [13]. The denatura-
tion temperature of pepsin in solution at pH 2 is 67.9670.015 °C
[13]. The effect of ionic force (m) on pepsin denaturation may be
explained by changes in the ionizable groups and alterations of the
electrostatic interactions. It has also been previously demonstrated
that the alkaline denaturation rate constant is accelerated by the
ionic strength [11].
There is widespread acceptance of the view that vagal stimu-
lation evokes the secretion of acid gastric juice rich in pepsin.
According to that, variability in human gastric secretion is high.
The SGF is an artiﬁcial dissolution medium that is intended to
represent a standardized way the stomach acid secretion in fasted
state. The composition for SGF is given in the section Reagents:
Test Solutions in USP-NF.
The dissolution medium may additionally contain a percentage
of surfactants, dispersing agents, or solubility enhancers when
either the capsule ﬁll or the active ingredient (or both), are
hydrophobic or water-insoluble. They may also be used if the
media as described in 〈1092〉 [30] is ineffective in dispersing the
capsule ﬁll or in achieving proper sink conditions for the active
ingredient.
The need for a surfactant and its particular concentration can
be justiﬁed from drug substance solubility investigations, that
include all common surfactant types, anionic (i.e., sodium dodecyl
sulfate (SDS)), cationic (i.e., cetyltrimethyl ammonium bromide
(CTAB)) and nonionic (i.e., polysorbate 80 (Tween 80) or (octox-
ynol 9 (Triton X100))) [17,25,28,8,9,26]. When a suitable surfactant
has been identiﬁed, different concentrations should be investi-
gated to identify the lowest concentration needed to achieve sink
conditions for the dissolution test. Typically, such concentration is
above the surfactant's critical micellar concentration (CMC).
When the concomitant use of surfactants and enzymes are
required for dissolution tests, a rational selection of the surfactant
to be used should be performed in order to reach reliable results.
Among the reasons that should be considered with this selection
are the interactions between the surfactants and enzymes. The
interaction between enzymes and surfactants has been widely
described in the literature [24]; however, this topic has not been
discussed for its implication in dissolution tests and no systematic
studies have been reported about the effect of surfactants on the
activity of the pepsin under the conditions used in USP dissolution
tests, i. e. temperature, pH, stirring and time. Besides, this inter-
action depends on both the type and the concentration of the
surfactant used. The monomeric or micellar form of the surfac-
tants, which is related with their CMC, is one of the main factors
that can affect the type of interaction with the enzymes. For water-
soluble proteins, interactions with surfactants can be broadly split
up into two regions: below and above the CMC [24]. Depending on
the concentration of the surfactant and its ionic character, an
unfolding or denaturation process of the enzyme could occur as a
consequence of their interaction [24].
The goal of this study was to evaluate the impact in pepsin
activity produced by the concomitant presence of surfactants
currently used in dissolution studies. USP-SGF was selected as
dissolution medium for this study.2. Materials and methodology
2.1. Reagents
USP Pepsin for assay RS, Lot FOM 228, having an activity of
7.7 U/mg (USP 2015 Pepsin Activity) was used. Pepsin from porcine
gastric mucosa lyophilized powder, 3200–4500 U/mg protein from
SIGMA-ALDRICHs (Lot. SLBL 1721V, 26.0 U/mg) was used as
reagent. Milli-Q water was used for all solutions preparations. The
SGF was prepared according to speciﬁcations described in USP 38
(USP, 2015 Reagent, test solutions). The 4.0% w/v trichloroacetic
acid (TCA) solution was prepared by diluting 5% TCA solution
(RICCAs, reagent grade) with water, and the diluted hydrochloric
acid solution (HCl Sol) was prepared by diluting 2.5 mL of 37%
hydrochloric acid (Fishers) to 1 l with water. The pH of the ﬁnal
solution was adjusted to 1.670.1 with 37% hydrochloric acid.
The substrate solution consisted of 2% w/v hemoglobin pro-
tease substrate USP RS, Lot FOM 231 in HCl Sol. The pH of the ﬁnal
solution was adjusted to a pH of 1.670.1 with 1 M HCl.
SDS (Spectrums, Lot 2DH221), CTAB (MP Biomedicals, Lot
MR31911), Tween 80 (Fishers, Lot 132307) and Triton X100
(Fishers, Lot 136597) were selected since they are the surfactants
most commonly used un dissolution media [17,25,26,28,8,9].
2.2. Standard curve of pepsin RS activity
Enzymatic activity of pepsin was performed using the method
“Activity of pepsin” described in the FCC 9 [33]. In this assay,
acidiﬁed hemoglobin is hydrolyzed by pepsin at 25 °C. This gives
TCA soluble peptides, which are detected by UV absorbance at
280 nm. Enzymatic activity is expressed as U/mg protein.
In order to construct a calibration reference curve, fresh stan-
dard solutions (SS) of 0.7, 0.9, 1.0 and 1.30 U/mL (0.09–0.17 mg/mL)
were prepared from a 0.2 mg/mL stock solution of pepsin RS in
HCl Sol.
2.2.1. Enzymatic reaction
SS tubes: Tubes (in duplicate) containing 1.0 mL of each of the
SS were placed into a water bath maintained at 2570.1 °C, added
with 5.0 mL of the hemoglobin substrate solution and mixed by
vortexing. Exactly 10 min after that, the reaction was stopped by
the addition of 10.0 mL of the TCA Solution.
SS blank tubes (SSB): Tubes (in duplicate) containing 1.0 mL of
each of the SS were placed into a water bath maintained at
2570.1 °C, added with 10.0 mL of TCA and mixed by vortexing.
Then, an aliquot of 5.0 mL of the hemoglobin substrate solution
was also added.
After 25 min, the content of SS and SSB tubes were ﬁltered
twice through a Whatman No. 41 ashless ﬁlter circle with a dia-
meter of 150 mm. The absorbance of each of the ﬁltrates was
measured at 280 nm using an AGILENT single beam UV–visible
spectrophotometer, in a 1-cm quartz cell. A blank solution was
prepared by transferring 1.0 mL HCl Sol into a single tube and
processed as described for SSB.
The net absorbance for the SS was calculated by subtracting the
average absorbance of the SSB from the average absorbance of the
corresponding SS. A standard curve of the net absorbance for each
SS versus its concentration (mg/ml) was established. The calibra-
tion curve was performed six times, and the results of these curves
were averaged in order to obtain an equation to be used to
determine the activity of the pepsin.
The Pepsin RS enzymatic activity showed linearity in the con-
centration range between 0.7 and 1.3 U/mL (0.09–0.17 mg/mL),
with a correlation coefﬁcient of 0.9997 (R2). The equation of the
average adjusted curve was calculated as y¼4.6647x0.00104.
This equation was used to calculate the activity of pepsin.
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Thus, in different studies either edestin, gelatin, egg albumin,
hemoglobin or human plasma has been used as substrates. Also,
the time of digestion, pH, temperature, and the parameters of
proteolytic activity varied in different studies.
USP and FCC methods specify hemoglobin as substrate and
therefore, the results using this method generally cannot be
extrapolated to other substrates or different testing conditions.
2.3. Activity of pepsin in SGF
In order to determine the activity of pepsin in similar condi-
tions to a dissolution procedure, 500 mL of a pepsin solution in
SGF (1.9 mg/mL) were stirred to 50 rpm and 37 °C using common
dissolution equipment (Vankel, VK 7010, Apparatus 2). After
30 min, an aliquot was withdrawn and diluted 1/50 mL with HCl
Sol in order to perform the enzymatic reaction (Section 2.2). This
conservative sampling time was selected based on the knowledge
that the opening time for crosslinked gelatin capsules was 15 min
[12].
The activity of pepsin was calculated according to Eq. (1):
Pepsin U=mg
 ¼ ASbð Þ  P
 
= m Cð Þ ð1Þ
AS¼average absorbance for the sample corrected for the aver-
age absorbance of the sample blanks
b¼y-intercept of the standard curve
P¼activity of the Pepsin RS
m¼slope of the standard curve
C¼concentration of the pepsin solution (mg/mL).
This assay was performed by fourteen fold. For comparison, the
activity of pepsin in HCl Sol (0.03 mg/mL) was also determined (in
duplicate).
2.4. Activity of pepsin in SGF in the presence of surfactants
The activity of pepsin was determined under the conditions
speciﬁed in Section 2.3 (the dissolution medium, stirring, and
temperature), with the addition of different amounts of surfac-
tants, according to Table 1. For this purpose, 500 mL of pepsin
solution in SGF (1.9 mg/mL) were transferred into a dissolution
vessel and heated at 37 °C and then, the desired amount of sur-
factant was added. After 30 min, 1 mL of the solution containing
the pepsin and surfactant was diluted to 50 mL with HCl Sol and
subjected to the enzymatic reaction described in Section 2.2. The
assay was conducted for each surfactant concentration in tripli-
cate. A control solution containing pepsin in SGF withoutTable 1
Surfactants and the concentration used.
Type Surfactant Concentration
Non ionic Polysorbate 80 (Tween 80) 0.0005%
0.005% [21]a
0.1%
0.5%
Polyethylene glycoltert-octylphenyl ether (Triton
X-100)
0.0005%
0.015% [27]a
0.1%
0.5%
Anionic Sodium dodecyl sulfate (SDS) 0.05%
0.20% [19]a
0.5%
0.8%
Cationic Cetyltrimethyl ammonium bromide (CTAB) 0.005
0.03% [21]a
0.05%
0.1%
a CMC (critical micellar concentration).surfactant was also run with each experiment. The activity of
pepsin was calculated according to Eq. (1).3. Results and discussion
The activity of pepsin in SGF determined under conditions
similar to a dissolution procedure was 25.471.3 U/mg. The value
obtained for pepsin in HCl Sol was 26.970.5 U/mg. Notice that for
the enzymatic activity a relative standard deviation of 710% from
the average is considered acceptable and therefore, in case of a
comparison, the values obtained in SGF and HCl Sol are not con-
sidered to be different.
3.1. Activity of pepsin in SGF in the presence of surfactants
3.1.1. Anionic surfactant
SDS is one of the most common and frequently used surfactant
in dissolution tests. SDS concentrations commonly used as solu-
bility enhancer of poorly water soluble drug substances are in the
range of 0.2–1% w/v (Oxcarbazepine Tablets, Tadalaﬁl Tablets,
Fenoﬁbrate Capsules, Efavirenz Capsules (USP monographs, 2015).
Fig. 1 shows the enzymatic activity of pepsin in presence of
SDS. When SDS concentration is below its CMC (0.05%), the pepsin
activity was reduced about 50% of its initial value. When SDS
concentration is at its CMC or above, a 10% or less of its initial value
was obtained. In both cases, the formation of a precipitate which
conferred turbidity to the solution was observed.
The reduction of the activity in the presence of SDS has already
been described for several enzymes and ascribed to the disruption
of their structures due to interaction with SDS [22,23]. The pre-
cipitate observed in our experiments is in agreement with the
results obtained by Komarov et al. [15], which found the inhibition
of pepsin by SDS to be due to precipitation of the enzyme which is
maximal at the isoelectric point for pepsin, pH 2.5. Additionally,Fig. 1. Activity of pepsin in the presence of SDS.
Fig. 2. Activity of pepsin in the presence of CTAB.
Fig. 3. Activity of pepsin in the presence of Tween 80 and Triton X100.
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67% (4 h) in the activity of the pepsin in presence of SDS 1.4% (at
pH 1.6 and with albumin as the substrate), suggesting an impor-
tant kinetic step in the unfolding enzyme process.
This behavior may negatively impact on dissolution studies of
crosslinked capsules. Indeed, Marchais et al. [18] observed that no
dissolution of carbamazepine occurred despite the presence of pep-
sin in SGF. A possible explanation may be the existence of an inter-
action between SDS and pepsin not allowing capsule disintegration.
Based on the above information, the concomitant use of SDS
and pepsin should be avoided in dissolution studies. Alternativelya
so called “pretreatment” should be applied, as it is stated in USP
General Chapters 〈711〉, 〈1092〉, 〈1094〉 and 〈2040〉 [29–32], when
the use of both pepsin and SDS is required for the dissolution test.
3.1.2. Cationic surfactants
There is currently no information in the literature regarding the
activity of pepsin in presence of CTAB. An interaction between pepsin
and CTAB was reported by Chakraborty et al. [4], although its impact
in the enzymatic activity was not quantiﬁed, and also, different
conditions than those described in this study where used. They
found that pepsin-induced interaction produced complexes, aggre-
gates, and micelles of CTAB with distinct physicochemical features. At
very low surfactant concentrations, much below CMC, the monomers
preferentially adsorb on to the oppositely charged peripheral pepsin
sites. Addition of further CTAB led to coacervation of the solution. The
unfolding of pepsin induced further surfactant adsorption on to the
pepsin sites, both in monomeric and aggregated forms.
In our experiments, the pepsin activity was not affected by any
of the CTAB concentration used in the dissolution medium, either
those above or below its CMC (Fig. 2). However, based on Chak-
raborty et al. [4] report, an interaction between pepsin and CTAB
cannot be ruled out. Taking this information into account, the
concentration of CTAB to be used as a solubility enhancer, and the
conditions of the assay should be considered as important factors
to avoid changes in the activity of the pepsin. More research isrequired if different conditions than those described here are need
to be used.
3.1.3. Non-ionic surfactants
Non-ionic surfactants generally do not cause inactivation or
denaturation of enzymes [2,34]. In accordance to this, our study
showed that Tween 80 and Triton X100, in all concentrations
assayed, did not produce changes in the enzymatic activity of
pepsin compared to the reference (Fig. 3).
Indeed, according to Jahan [13], polysorbates act as stabilizers
for pepsin. It is believed that such surfactants are preferentially
adsorbed at the interface and prevent protein to be adsorbed to it
and its subsequent unfolding.4. Conclusion
When SGF was used as the dissolution media, a marked
reduction in the activity of pepsin was observed in presence of
SDS, in concentrations commonly used as a solubility enhancer. In
contrast, no changes in pepsin activity were observed under
similar conditions when the cationic and non-ionic surfactant
models were used. The results reported here can contribute
toward a more rational basis when selecting appropriate surfac-
tants during required concomitant use of pepsin, and/or to
describe a speciﬁc approach in setting up the dissolution test.Acknowledgments
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